News und Analysen
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on April 1, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement
Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss
Newron Presents 2024 Financial Results and Provides 2025 Outlook
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral
Novocure to Report First Quarter 2025 Financial Results
Novocure (NASDAQ: NVCR) will report financial results for the first quarter 2025 on April 24, 2025, before the U.S. financial markets open. Novocure management will host a conference call and
Lonza Implements its Simplified and Streamlined Operating Model
EQS-News: Immunic, Inc. to Participate in Scientific and Industry Conferences in April
European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO®, the company’s bivalent respiratory syncytial virus
Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets
Navidea Biopharmaceuticals, Inc. (“Navidea” or the “Company”) today announced that its Board of Directors has elected to extend the Company’s Section 382 Rights Agreement (the “Section 382 Rights
ICON plc Schedules First Quarter 2025 Earnings Conference Call
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the first quarter 2025
Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Sensorion Announces Webconference, in French, for its Retail Shareholders on April 7, 2025
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss
Uni-Bio Science Group Limited Announces 2024 Annual Results
Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending
Evolva Holding SA shareholders elect Clearway representatives to the Board of Directors
EQS-News: Formycon reports on a successful financial year 2024 with strong operational progress and continuous strengthening of its market position
GA-ASI and Barzan Holdings Sign MOU
Companies Will Collaborate on the Development of Advanced Battle Management
DOHA, QA / ACCESS Newswire / January 19, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) -- the world
Datavault AI und The Dream Bowl setzen neue Maßstäbe in der Sportinnovation mit der weltweit ersten tokenisierten Autogrammstunde mit aktuellen und zukünftigen NFL-Stars – live auf ESPN+.
30 ehemalige NFL-Spieler aus verschiedenen NFL-Teams werden vor Ort bis zu 3.000 Erinnerungsstücke des Dream Bowl wie Helme, Fußbälle, Trikots und Live-Autogramme von Notable Live signieren.
Datavault AI and The Dream Bowl to Set New Benchmark in Sports Innovation with World’s First Tokenized Autograph Session, Featuring Current and Future NFL Stars - Live on ESPN+
30 former NFL star players from different NFL Teams will autograph on-site up to 3,000 The Dream Bowl memorabilia items such as helmets, footballs, jerseys, and live-autographs by Notable
Revolution im Bereich Tiernahrung: Zwei neue weltweite Umfragen zeigen wachsende Offenheit der Tierhalter für nachhaltige Ernährung von Hunden und Katzen
London, UK / Access Newswire / 14. November 2025 / Zwei zukunftsweisende in der Fachzeitschrift Animals veröffentlichte Studien haben eingehend untersucht, wie Hunde- und Katzenhalter
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats
LONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published in the journal Animals have explored in depth how dog and cat guardians perceive more sustainable pet
Industrielle Viehzucht gefährdet Klimaziele, wie bedeutsame internationale Studie zeigt
LONDON, UK / ACCESS Newswire / 11. November 2025 / Eine neue Studie in Animals zeigte auf, dass die industrielle Viehzucht eine der mächtigsten – und dennoch beharrlich vernachlässigten –
Climate Goals Threatened by Industrialised Animal Farming, Reveals Key International Study
LONDON, UK / ACCESS Newswire / November 11, 2025 / A new study in Animals highlights that industrialized animal farming is one of the most powerful - yet persistently neglected - forces
Saudi Arabia Assumes Chairmanship of INTOSAI
SHARM EL-SHEIKH, EG / ACCESS Newswire / October 31, 2025 / Today, the Kingdom of Saudi Arabia solidified its global leadership in public financial auditing and accounting by winning the
TruMerit's Peter Preziosi Elected President of the Conference of NGOs in Consultative Relationship With the United Nations
NEW YORK CITY, NEW YORK / ACCESS Newswire / October 30, 2025 / TruMerit President and CEO Peter Preziosi has been elected President of the Conference of Non-Governmental Organizations in